Review of clinical course and treatment of ovarian hyperstimulation syndrome (OHSS)

被引:167
作者
Delvigne, A [1 ]
Rozenberg, S [1 ]
机构
[1] Free Univ Brussels, Hosp St Pierre, Dept Obstet & Gynaecol, IVF Ctr, Brussels, Belgium
关键词
clinical course; coasting; IVF; OHSS; treatment;
D O I
10.1093/humupd/dmg005
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
The ovarian hyperstimulation syndrome (OHSS) is a rare iatrogenic complication of ovarian stimulation occurring during the luteal phase or during early pregnancy. This complication is unusual as it is not the consequence of a treatment which is vital or mandatory for the patient's health. Nevertheless, it can be accompanied by severe morbidity and may even be fatal. Data pertaining to the clinical course and consequences of OHSS in women and its treatment were searched using Medline, Current Contents and PubMed. To date, only a few studies have collected a large number of cases of OHSS. The clinical course of OHSS may involve, according to its severity and the occurrence of pregnancy, electrolytic imbalance, neurohormonal and haemodynamic changes, pulmonary manifestations, liver dysfunction, hypoglobulinaemia, febrile morbidity, thromboembolic phenomena, neurological manifestations and adnexal torsion. Treatment of the acute phase relies only on an empirical and symptomatic approach. The general approach will be adapted to the levels of severity. Specific approaches such as paracentesis, pleural puncture, surgical approach of OHSS and specific medication during OHSS were evaluated sporadically. More adequate treatment methods would require a better understanding of the underlying pathophysiological mechanisms, to promote an aetiological therapeutic approach. Properly conducted studies, including large numbers of patients are required in order to determine the best method of prevention and management.
引用
收藏
页码:77 / 96
页数:20
相关论文
共 50 条
  • [41] A qualitative systematic review of coasting, a procedure to avoid ovarian hyperstimulation syndrome in IVF patients
    Delvigne, A
    Rozenberg, S
    HUMAN REPRODUCTION UPDATE, 2002, 8 (03) : 291 - 296
  • [42] Polymorphisms of VEGF and VEGF receptors are associated with the occurrence of ovarian hyperstimulation syndrome (OHSS)-a retrospective case-control study
    Nouri, Kazem
    Haslinger, Peter
    Szabo, Ladislaus
    Sator, Michael
    Schreiber, Martin
    Schneeberger, Christian
    Pietrowski, Detlef
    JOURNAL OF OVARIAN RESEARCH, 2014, 7
  • [43] Role of Serum miRNAs in the Prediction of Ovarian Hyperstimulation Syndrome in Polycystic Ovarian Syndrome Patients
    Zhao, Chun
    Liu, Xiaoguang
    Shi, Zhonghua
    Zhang, Jing
    Zhang, Junqiang
    Jia, Xuemei
    Ling, Xiufeng
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2015, 35 (03) : 1086 - 1094
  • [44] Early and Late Ovarian Hyperstimulation Syndrome: Two Distinct Clinical Entities
    Mishra, Vineet Vashisht
    Devi, Anju Dinesh
    Aggarwal, Rohina Somesh
    Jasani, Anil Fulchand
    Vachhani, Mitesh Vallabhdas
    Khurana, Snigdha Ashish
    KUWAIT MEDICAL JOURNAL, 2013, 45 (01): : 21 - 25
  • [45] Intravenous albumin for preventing severe ovarian hyperstimulation syndrome: a Cochrane review
    Aboulghar, M
    Evers, JH
    Al-Inany, H
    HUMAN REPRODUCTION, 2002, 17 (12) : 3027 - 3032
  • [46] Ovarian hyperstimulation syndrome: pathophysiology, staging, prediction and prevention
    Nastri, C. O.
    Teixeira, D. M.
    Moroni, R. M.
    Leitao, V. M. S.
    Martins, W. P.
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2015, 45 (04) : 377 - 393
  • [47] Preventing ovarian hyperstimulation syndrome: cabergoline versus coasting
    Esinler, Ibrahim
    Bozdag, Gurkan
    Karakocsokmensuer, Lale
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2013, 288 (05) : 1159 - 1163
  • [48] Preventing ovarian hyperstimulation syndrome: cabergoline versus coasting
    Ibrahim Esinler
    Gurkan Bozdag
    Lale Karakocsokmensuer
    Archives of Gynecology and Obstetrics, 2013, 288 : 1159 - 1163
  • [49] Prednisone combined with letrozole reduced risk of ovarian hyperstimulation syndrome (OHSS) in women undergoing long-term gonadotropin-releasing hormone analog treatment
    Fang, Luyan
    Ruan, Mengjia
    Yang, Shuangqing
    Qu, Xianqin
    Chen, Hui
    Zhao, Junzhao
    Cheng, Jing
    ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (08) : 8837 - 8847
  • [50] Comparison of bevacizumab and cabergoline in the treatment of ovarian hyperstimulation syndrome in a rat model
    Engin-Ustun, Yaprak
    Yilmaz, Saynur
    Timur, Hakan
    Ustun, Yusuf
    Moraloglu, Ozlem
    Deveer, Ruya
    Yilmaz, Nafiye
    GYNECOLOGICAL ENDOCRINOLOGY, 2013, 29 (09) : 851 - 854